Finance

Lists
001067:KRX
JW Pharmaceutical(2Pb) Pref Shs
49 850,00 KRW
-0,10%
(-50,00) 1D
16-окт., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001067...
Open
49 000 KRW
High
49 850 KRW
Low
49 000 KRW
Mkt. cap
607,55 млд
Avg. vol.
36,00
Volume
0,00
Dividend
1,30%
Quarterly dividend
162 KRW
Ex-dividend date
2023-ж., 27-дек.
P/E ratio
11,89
52-wk high
61 500 KRW
52-wk low
38 500 KRW
EPS
4 193 KRW
Shares outstanding
209,97 миң
No. of employees
1 миң
Open
49 000 KRW
High
49 850 KRW
Low
49 000 KRW
Mkt. cap
607,55 млд
Avg. vol.
36,00
Volume
0,00
Dividend
1,30%
Quarterly dividend
162 KRW
Ex-dividend date
2023-ж., 27-дек.
P/E ratio
11,89
52-wk high
61 500 KRW
52-wk low
38 500 KRW
EPS
4 193 KRW
Shares outstanding
209,97 миң
No. of employees
1 миң
News stories
From web sources and news partners
About JW Pharmaceutical(2Pb) Pref Shs
CEOLee, Kyung Ha
Employees1,05 миң
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
200,02 млд
198,94 млд
199,88 млд
222,02 млд
Cost of goods sold
105,39 млд
109,09 млд
101,43 млд
116,73 млд
Cost of revenue
105,39 млд
109,09 млд
101,43 млд
116,73 млд
Research and development expenses
7,33 млд
15,27 млд
9,38 млд
11,86 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,58 млд
60,42 млд
55,91 млд
59,90 млд
Operating expense
62,60 млд
80,98 млд
64,88 млд
71,95 млд
Total operating expenses
167,99 млд
190,07 млд
166,31 млд
188,68 млд
Operating income
32,03 млд
8,87 млд
33,58 млд
33,34 млд
Other non operating income
-4,64 млд
8,03 млд
1,21 млд
835,27 млн
EBT including unusual items
27,85 млд
17,49 млд
35,20 млд
34,76 млд
EBT excluding unusual items
27,85 млд
15,96 млд
35,20 млд
34,76 млд
Income tax expense
-2,74 млд
2,18 млд
7,72 млд
6,86 млд
Effective tax rate
-9,83%
12,44%
21,93%
19,75%
Other operating expenses
-
-
-
-
Net income
30,59 млд
15,32 млд
27,48 млд
27,89 млд
Net profit margin
15,29%
7,70%
13,75%
12,56%
Earnings per share
1,27 миң
-
-
-
Interest and investment income
-
3,34 млд
-
-
Interest expense
-
-4,42 млд
-
-
Net interest expenses
-
-1,09 млд
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36,72 млд
13,65 млд
38,56 млд
38,37 млд
Gain or loss from assets sale
5,12 млн
3,00 миң
-10,00 млн
3,00 миң
AI content may include mistakes. Learn more
Google колдонмолору